Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Patent: 10,392,439

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,392,439
Title:Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
Abstract: The present invention provides methods for treating, preventing or reducing the severity of allergic reactions. The present invention also provides methods for enhancing the efficacy and/or safety of an allergen-specific immunotherapy (SIT) regimen. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R.alpha.) antagonist such as an anti-IL-4R.alpha. antibody.
Inventor(s): Stahl; Neil (Carmel, NY), Orengo; Jamie M (Cortlandt Manor, NY), Murphy; Andrew J. (Croton-on-Hudson, NY), Gandhi; Namita (New York, NY), Graham; Neil (Croton-on-Hudson, NY)
Assignee: Regeneron Pharmaceuticals, Inc. (Tarrytown, unknown)
Application Number:14/294,544
Patent Claims:see list of patent claims

Details for Patent 10,392,439

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals DUPIXENT dupilumab INJECTABLE; INJECTION 761055 001 2017-03-28   Start Trial Regeneron Pharmaceuticals, Inc. (Tarrytown, unknown) 2039-09-04 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.